GSK PLC
(LSE:GSK)
£
13.97
0.16 (1.16%)
Market Cap: 57.00 Bil
Enterprise Value: 69.85 Bil
PE Ratio: 22.90
PB Ratio: 4.07
GF Score: 69/100 
GlaxoSmithKline PLC at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019 / 05:00PM GMT
Release Date Price:
£15.95
(+0.60%)
Keyur Parekh
Goldman Sachs Group Inc., Research Division - Equity Analyst
Good morning, and thank you all for joining us. Hal, real pleasure to have you join us today, so thank you very much for your time.
Hal V. Barron
GlaxoSmithKline plc - Chief Scientific Officer, President of R&D and Director
Thank you for the invitation.
Questions & Answers
Keyur Parekh
Goldman Sachs Group Inc., Research Division - Equity Analyst
You've just come back from 2 big medical conferences, clearly. ASCO pharma, important from your prospective. If you can give us a few kind of thoughts on how you thought ASCO was, kind of your takeaways as it relates to the broader kind of concept, community and feel. And then we'll go into more kind of GSK-related questions.
Hal V. Barron
GlaxoSmithKline plc - Chief Scientific Officer, President of R&D and Director
Sure. How would I describe ASCO? Every year, ASCO has got a different theme. I would say, on a high level, my takeaway
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers